Capital raised by Odyssey Therapeutics
1 Form D filing · first filed Jun 2025 · Boston, MA
President & CEO
Signatory on Odyssey Therapeutics's Form D filings · $214.0M raised across 1
Gary D. Glick is on file as President & CEO at Odyssey Therapeutics in Boston, MA. Odyssey Therapeutics has 1 Form D filing on record, $214.0M raised in total. Gary D. Glick appears as a signatory on the company's filings.
In a strategic collaboration with Terray Therapeutics, Odyssey is co-developing first-in-class transcription factor therapies. This program combines Odyssey's expertise in immunology and transcription factor biology with Terray's AI-powered drug discovery platform, tNova, to discover and develop small molecule medicines.
